2-(4-Dihydroxyborane)phenyl-4-carboxyquinoline
95%
blur_circular Chemical Specifications
description Product Description
This chemical is primarily utilized in the field of medicinal chemistry, particularly in the development of boron-containing compounds for cancer therapy. It serves as a key intermediate in the synthesis of boronated molecules, which are essential for Boron Neutron Capture Therapy (BNCT). BNCT is an advanced radiotherapy technique that targets cancer cells with high precision, minimizing damage to surrounding healthy tissues. The compound’s structure, featuring a boronic acid group, allows it to selectively accumulate in tumor cells, making it a promising candidate for therapeutic applications. Additionally, its quinoline moiety contributes to its potential use in fluorescence-based imaging, aiding in the visualization and tracking of cancer cells during treatment. Researchers also explore its role in designing novel inhibitors for enzymes involved in disease pathways, further expanding its utility in drug discovery.
format_list_bulleted Product Specification
| Test Parameter | Specification |
|---|---|
| Appearance | Yellow Solid |
| Purity (%) | 94.5-100 |
| Infrared Spectrum | Conforms to Structure |
| NMR | Conforms to Structure |
shopping_cart Available Sizes & Pricing
Cart
No products